Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial
Giornale di Clinica Nefrologica e Dialisi · 31.12.2025 · 37 (Suppl.1) · 17-18
DOI: 10.33393/gcnd.2025.3744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Giornale di Clinica Nefrologica e Dialisi, online erschienen am 31.12.2025. Verfasst von Giovanni Piscopo. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
FIGURA 1 -Incidenza di almeno un evento avverso e incidenza di diarrea.FIGURA 2 -Confronto eGFR su scala logaritmica a 12 mesi e a 24 mesi.
Zitieren
APA
Piscopo, G. (2025). Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial. Giornale di Clinica Nefrologica e Dialisi, 37(Suppl.1), 17-18. https://doi.org/10.33393/gcnd.2025.3744
Vancouver
Piscopo G. Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial. Giornale di Clinica Nefrologica e Dialisi. 2025;37(Suppl.1):17-18. doi:10.33393/gcnd.2025.3744
BibTeX
@article{Piscopo2025,
author = {Piscopo, Giovanni},
title = {Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial},
journal = {Giornale di Clinica Nefrologica e Dialisi},
year = {2025},
volume = {37},
number = {Suppl.1},
pages = {17--18},
doi = {10.33393/gcnd.2025.3744}
}
EUVIMED